학술논문

Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
Document Type
Article
Source
In: Journal of Cancer Research and Clinical Oncology. (Journal of Cancer Research and Clinical Oncology, July 2021, 147(7):2145-2152)
Subject
Language
English
ISSN
14321335
01715216